Gail Boudreaux - Jul 22, 2024 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol
ELV
Transactions as of
Jul 22, 2024
Transactions value $
-$17,033,395
Form type
4
Date filed
7/23/2024, 05:02 PM
Previous filing
Mar 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Sale -$548K -1.1K -0.68% $498.50 160K Jul 22, 2024 Direct F1
transaction ELV Common Stock Sale -$10.4M -20.8K -13.02% $500.36 139K Jul 22, 2024 Direct F1, F2
transaction ELV Common Stock Sale -$3.32M -6.62K -4.77% $501.40 132K Jul 22, 2024 Direct F1, F3
transaction ELV Common Stock Sale -$1.13M -2.25K -1.7% $502.23 130K Jul 22, 2024 Direct F1, F4
transaction ELV Common Stock Sale -$504K -1K -0.77% $503.67 129K Jul 22, 2024 Direct F1, F5
transaction ELV Common Stock Sale -$1.13M -2.25K -1.74% $504.27 127K Jul 22, 2024 Direct F1, F6
holding ELV Common Stock 60 Jul 22, 2024 Shares Held in Spouse's Revocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 19, 2024.
F2 This transaction was executed in multiple trades at prices ranging from $499.82 to $500.81. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $500.83 to $501.79. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $501.96 to $502.65. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $503.05 to $503.95. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $504.1 to $504.99. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.